- Home
- CISS vs ISPC Comparison
CISS vs ISPC Comparison
Compare CISS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | ISPC |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 2.2M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CISS | ISPC |
|---|---|---|
| Price | $0.87 | $0.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.0M | ★ 9.0M |
| Earning Date | 02-19-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,291,115.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $0.18 |
| 52 Week High | $5.93 | $2.16 |
Technical Indicators
Market Signals| Indicator | CISS | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 36.66 |
| Support Level | $0.14 | N/A |
| Resistance Level | $3.77 | $0.44 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 11.67 | 0.00 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.